Additional Listing

RNS Number : 5196T

The MedicX Fund Limited

29 September 2010

 



For immediate release                                                                                              29 September 2010

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Additional Listing

Application has been made for 172,370 ordinary shares of no par value in the Company ("Shares") to be admitted to the Official List of the FSA and to trading on the Main Market of the London Stock Exchange ("Admission").  It is expected that Admission will become effective on 30 September 2010. The application is being made pursuant to the scrip dividend scheme (the "Scrip Dividend Alternative"), in lieu of cash for the September 2010 interim dividend in respect of the quarter ended 30 June 2010.  Elections for a scrip dividend were received in respect of 6.5% of the ordinary shares in issue as at the record date of 20 August 2010. When issued, the Shares will rank pari passu with the existing ordinary shares.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.hemscott.com/nsm.do).

End

For further information please contact:

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

MedicX Fund                                                                 [phone]

David Staples, Chairman

Collins Stewart Europe Limited                                        [phone]

Andrew Zychowski/Lucy Lewis

Buchanan Communications                                              [phone]

Charles Ryland/Lisa Baderoon/George Prassas

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 57 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 35 people operating across the UK.  

The Company's website address is www.medicxfund.com 

 

END

 

 

LISGMGZLZLFGGZM